Literature DB >> 2438727

Interaction of bradykinin and des-Arg9-bradykinin with isolated pig coronary arteries: mechanical and electrophysiological events.

J L Beny, P Brunet, H Huggel.   

Abstract

This paper describes the effect of bradykinin (BK) and des-Arg9-BK on the isometric tension and smooth muscle membrane potential of transverse strips of pig coronary artery. BK causes a relaxation of contracted muscle. This effect is particularly evident in muscle which has previously been contracted by acetylcholine. The relaxation is accompanied by a transient hyperpolarization of the vascular smooth muscle. Des-Arg9-BK, in contrast, causes a contraction of the muscle which is not accompanied by a significant change of transmembrane potential. The relaxing action of BK depends on the presence of the endothelium. In a "cascade" experiment, evidence is presented that a relaxing factor is released by the endothelium in response to BK. Thus the perfusate from a BK-stimulated intact artery can cause the relaxation of a pre-contracted de-endothelialized artery. We conclude that the endothelium has B2-receptors which cause the release of a humoral factor which hyperpolarizes and relaxes the muscle. The contracting action of des-Arg9-BK does not depend on the endothelium and appears to be mediated through B1-receptors directly on smooth muscle by pharmacomechanical coupling.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2438727     DOI: 10.1016/0167-0115(87)90061-9

Source DB:  PubMed          Journal:  Regul Pept        ISSN: 0167-0115


  13 in total

1.  A comparison of bradykinin- and capsaicin-induced myocardial and coronary effects in isolated perfused heart of guinea-pig: involvement of substance P and calcitonin gene-related peptide release.

Authors:  S Manzini; F Perretti; L De Benedetti; P Pradelles; C A Maggi; P Geppetti
Journal:  Br J Pharmacol       Date:  1989-06       Impact factor: 8.739

2.  Hemoglobin causes both endothelium-dependent and endothelium-independent contraction of the pig coronary arteries, independently of an inhibition of EDRF effects.

Authors:  J L Bény; P C Brunet; V Van der Bent
Journal:  Experientia       Date:  1989-02-15

3.  Evidence for in vitro expression of B1 receptor in the mouse trachea and urinary bladder.

Authors:  M Trevisani; F Schmidlin; M Tognetto; F P Nijkamp; J P Gies; N Frossard; S Amadesi; G Folkerts; P Geppetti
Journal:  Br J Pharmacol       Date:  1999-03       Impact factor: 8.739

4.  An evaluation of potassium ions as endothelium-derived hyperpolarizing factor in porcine coronary arteries.

Authors:  J L Bény; O Schaad
Journal:  Br J Pharmacol       Date:  2000-11       Impact factor: 8.739

5.  Effect of 5-hydroxytryptamine on the membrane potential of endothelial and smooth muscle cells in the pig coronary artery.

Authors:  M Frieden; J L Bény
Journal:  Br J Pharmacol       Date:  1995-05       Impact factor: 8.739

6.  Vascular mode of action of kinin B1 receptors and development of a cellular model for the investigation of these receptors.

Authors:  L Levesque; G Drapeau; J H Grose; F Rioux; F Marceau
Journal:  Br J Pharmacol       Date:  1993-08       Impact factor: 8.739

7.  Endothelium-dependent relaxations mediated by inducible B1 and constitutive B2 kinin receptors in the bovine isolated coronary artery.

Authors:  G R Drummond; T M Cocks
Journal:  Br J Pharmacol       Date:  1995-11       Impact factor: 8.739

8.  Endothelium-dependent hyperpolarization caused by bradykinin in human coronary arteries.

Authors:  M Nakashima; J V Mombouli; A A Taylor; P M Vanhoutte
Journal:  J Clin Invest       Date:  1993-12       Impact factor: 14.808

9.  Simultaneous oscillations in the membrane potential of pig coronary artery endothelial and smooth muscle cells.

Authors:  P Y von der Weid; J L Bény
Journal:  J Physiol       Date:  1993-11       Impact factor: 5.182

10.  Mechanisms controlling caffeine-induced relaxation of coronary artery of the pig.

Authors:  V van der Bent; J L Bény
Journal:  Br J Pharmacol       Date:  1991-08       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.